Arborea targets 2027 opening for Portuguese algae factory

Arborea targets 2027 opening for Portuguese algae factory

Arborea advances Portuguese algae production towards its first commercial factory. The company reports completion of its Series A fundraising and further construction progress, with BioSolar Leaf cultivation scheduled to support ingredient manufacturing from mid-2027.


IN Brief:

  • Arborea reports progress on its first full-scale microalgae manufacturing facility in Portugal, targeting operations from mid-2027.
  • Its BioSolar Leaf system uses sunlight and carbon dioxide to cultivate photosynthetic organisms for food ingredients.
  • Initial commercial applications centre on spirulina, with extracted protein ingredients planned as a subsequent development.

Microalgae technology developer Arborea has reported further progress towards its first full-scale manufacturing facility in Portugal, with operations targeted from mid-2027 and the initial commercial programme focused on spirulina-derived food ingredients.

The Anglo-Portuguese company confirmed the updated manufacturing position during Fi Europe 2026 in Frankfurt, where its BioSolar Leaf cultivation platform received a Future Foodtech Innovation Award. Arborea has also completed its Series A fundraising and is progressing construction of the Portuguese facility.

The project forms part of an established development programme rather than a newly announced factory investment. Arborea had previously identified 2027 as its intended commercial production year, with the latest update providing a more specific target of mid-2027 alongside further information about its ingredient rollout.

BioSolar Leaf is designed to cultivate microalgae and other photosynthetic microorganisms using sunlight and carbon dioxide. The resulting biomass provides starting material for ingredients including proteins, pigments and other functional components used in food and nutrition applications.

The system differs from conventional fermentation processes that depend on supplying an organic carbon source to microorganisms growing inside stirred cultivation vessels. Arborea uses photosynthetic organisms that convert carbon dioxide into biomass when suitable light, nutrients and cultivation conditions are maintained.

Its technology incorporates gas-permeable membranes designed to facilitate the uptake of carbon dioxide without requiring the same gas pressurisation arrangements used in some other cultivation systems. Arborea has developed the approach to support growth using atmospheric carbon dioxide or suitable industrial carbon dioxide sources.

The use of membranes is central to the company’s cultivation design. Gas transfer must be sufficient to support biological growth, while the system must maintain the conditions required for the selected organisms to remain productive.

Photosynthetic cultivation also depends on the availability and distribution of light. Dense cultures can limit light penetration, creating differences in the conditions experienced by organisms within the same production system.

Maintaining suitable growth conditions as production expands is therefore an engineering challenge as well as a biological one. Temperature, nutrient delivery, gas exchange and light availability all influence the productivity and consistency of the resulting biomass.

Arborea describes its system as a modular cultivation platform intended to address some of these constraints. The company has previously operated a 100-square-metre demonstration facility in Portugal, providing an intermediate stage between laboratory development and the proposed full-scale manufacturing operation.

Its commercial factory is intended to extend that technology into industrial ingredient production. The company has not disclosed a verified annual output capacity for the new facility in its latest update, nor has it provided a complete investment figure or confirmed a commissioning date.

Construction progress was discussed by Dr Kaly Chatakondu, Arborea’s global commercial director, during Fi Europe. He also confirmed completion of the company’s Series A fundraising, although the amount associated with the latest financing milestone was not specified.

Arborea previously secured a €5m investment supported by Indico Capital Partners and Banco Português de Fomento in December 2024. The latest fundraising update should not be interpreted as another separately quantified €5m investment or combined with earlier financing without further information.

The company’s initial commercial focus is BioSolar Spirulina, a range of ingredients derived from cultivated spirulina. Applications being developed with partner Vita Actives include nutraceuticals, smoothies, slushies and ice cream.

Spirulina has established uses in food and nutrition, including as a source of pigments and protein-rich biomass. However, the properties of an ingredient derived from spirulina depend on the cultivated organism, manufacturing process and degree of subsequent processing.

Whole or minimally processed biomass behaves differently from extracted ingredient fractions. Products using spirulina as a colouring component, for example, may have different purity, stability and formulation requirements from ingredients intended to provide a concentrated source of protein.

Arborea expects extracted spirulina proteins to follow its initial commercial offerings. The company has indicated that this subsequent stage could begin approximately a year after the first products, reflecting additional development and processing requirements.

Protein extraction involves separating the target components from cultivated biomass. Depending on the process selected, this can require biomass concentration, cell disruption, separation and purification before an ingredient is ready for formulation or commercial supply.

The efficiency of these operations influences ingredient yield and production economics. A cultivation system may produce biomass effectively while still requiring substantial downstream processing to deliver ingredients with the composition and functionality needed by food manufacturers.

Ingredient quality must also remain consistent between production batches. Colour, flavour, dispersibility, protein composition and microbiological quality can affect whether a material is suitable for a particular application.

In ice cream and chilled beverages, the formulation requirements differ from those associated with protein enrichment in a nutritional product. Ingredients must remain compatible with the intended manufacturing conditions and deliver acceptable performance during storage and consumption.

Arborea has identified commercial offtake and multinational agreements as part of its development programme. These arrangements suggest established customer engagement, but the company has not disclosed all counterparties, contracted volumes or confirmed delivery schedules.

Production economics remain an important consideration as the facility approaches commissioning. The proposed system avoids the need for fertile agricultural land, but its commercial performance will depend on more than the area occupied by the cultivation equipment.

Energy demand, nutrient consumption, water use, biomass recovery, equipment maintenance and downstream processing all contribute to the operating requirements of an industrial facility. These factors must be assessed alongside the quantity and value of the finished ingredients produced.

Arborea promotes the potential environmental benefits of using photosynthesis and carbon dioxide as inputs to ingredient manufacture. Its latest factory update does not, however, provide independently verified commercial-scale figures for production cost, carbon balance or resource consumption.

The technology is also being developed against a wider backdrop of interest in alternative protein sources and functional food ingredients. European research and investment programmes have supported microalgae cultivation, but the transition from demonstration facilities to commercial production remains dependent on repeatable biological and engineering performance.

Arborea’s Portuguese project provides an opportunity to test those requirements at larger scale. The existing demonstration work establishes technical experience, while the planned factory will need to demonstrate sustained ingredient production under commercial operating conditions.

The company is targeting mid-2027 for operations and expects spirulina-based ingredients to provide its initial route to market. Construction, commissioning, customer deliveries and measured factory performance will determine the extent to which the BioSolar Leaf platform progresses from demonstrated cultivation technology into industrial food ingredient supply.


Stories for you


  • Arborea targets 2027 opening for Portuguese algae factory

    Arborea targets 2027 opening for Portuguese algae factory

    Arborea advances Portuguese algae production towards its first commercial factory. The company reports completion of its Series A fundraising and further construction progress, with BioSolar Leaf cultivation scheduled to support ingredient manufacturing from mid-2027.


  • Nestlé invests €2.5m in Spanish chocolate production

    Nestlé invests €2.5m in Spanish chocolate production

    Nestlé has adapted Spanish chocolate production for international ChocoTRIO supply. Its La Penilla de Cayón factory has received €2.5m for specialised biscuit-baking technology and precision filling equipment, enabling manufacture of the three-component chocolate range.